Back

Eicosatetraynoic Acid Regulates Pro-Fibrotic Pathways in an Induced Pluripotent Stem Cell Derived Macrophage:Human Intestinal Organoid Model of Crohns Disease

Jurickova, I.; Dreskin, B.; Angerman, E.; Bonkowski, E.; Tominaga, K.; Iwasawa, K.; Braun, T.; Takebe, T.; Helmrath, M.; Haberman, Y.; Wells, J.; Denson, L.

2024-01-30 molecular biology
10.1101/2024.01.30.577959 bioRxiv
Show abstract

Background and AimsWe previously identified small molecules predicted to reverse an ileal gene signature for future Crohns Disease (CD) strictures. Here we used a new human intestinal organoid (HIO) model system containing macrophages to test a lead candidate, eicosatetraynoic acid (ETYA). MethodsInduced pluripotent stem cell lines (iPSC) were derived from CD patients and differentiated into macrophages and HIOs. Macrophages and macrophage:HIO co-cultures were exposed to lipopolysaccharide (LPS) with and without ETYA pre-treatment. Cytospin and flow cytometry characterized macrophage morphology and activation markers, and RNA sequencing defined the global pattern of macrophage gene expression. TaqMan Low Density Array, Luminex multiplex assay, immunohistologic staining, and sirius red polarized light microscopy were performed to measure macrophage cytokine production and HIO pro-fibrotic gene expression and collagen content. ResultsiPSC-derived macrophages exhibited morphology similar to primary macrophages and expressed inflammatory macrophage cell surface markers including CD64 and CD68. LPS-stimulated macrophages expressed a global pattern of gene expression enriched in CD ileal inflammatory macrophages and matrisome secreted products, and produced cytokines and chemokines including CCL2, IL1B, and OSM implicated in refractory disease. ETYA suppressed CD64 abundance and pro-fibrotic gene expression pathways in LPS stimulated macrophages. Co-culture of LPS-primed macrophages with HIO led to up-regulation of fibroblast activation genes including ACTA2 and COL1A1, and an increase in HIO collagen content. ETYA pre-treatment prevented pro-fibrotic effects of LPS-primed macrophages. ConclusionsETYA inhibits pro-fibrotic effects of LPS-primed macrophages upon co-cultured HIO. This model may be used in future untargeted screens for small molecules to treat refractory CD.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
Gastro Hep Advances
11 papers in training set
Top 0.1%
9.2%
2
Mucosal Immunology
47 papers in training set
Top 0.1%
7.0%
3
Scientific Reports
3612 papers in training set
Top 9%
6.9%
4
PLOS ONE
5266 papers in training set
Top 24%
6.9%
5
American Journal of Physiology-Gastrointestinal and Liver Physiology
14 papers in training set
Top 0.1%
6.4%
6
Stem Cell Research & Therapy
30 papers in training set
Top 0.1%
5.0%
7
Cellular and Molecular Gastroenterology and Hepatology
46 papers in training set
Top 0.3%
3.5%
8
Frontiers in Immunology
638 papers in training set
Top 4%
2.9%
9
Molecular Medicine
11 papers in training set
Top 0.1%
2.5%
50% of probability mass above
10
JCI Insight
277 papers in training set
Top 3%
2.5%
11
European Respiratory Journal
59 papers in training set
Top 0.4%
2.5%
12
Journal of Cellular and Molecular Medicine
20 papers in training set
Top 0.1%
2.2%
13
Molecular Therapy - Nucleic Acids
25 papers in training set
Top 0.2%
2.0%
14
Inflammatory Bowel Diseases
16 papers in training set
Top 0.1%
1.7%
15
American Journal of Respiratory and Critical Care Medicine
43 papers in training set
Top 0.5%
1.5%
16
Stem Cell Reports
130 papers in training set
Top 1%
1.5%
17
American Journal of Physiology-Lung Cellular and Molecular Physiology
43 papers in training set
Top 0.4%
1.4%
18
The FASEB Journal
194 papers in training set
Top 3%
1.4%
19
Journal of Translational Medicine
57 papers in training set
Top 1%
1.4%
20
The Journal of Heart and Lung Transplantation
11 papers in training set
Top 0.3%
1.2%
21
International Journal of Molecular Sciences
494 papers in training set
Top 10%
1.2%
22
Experimental & Molecular Medicine
14 papers in training set
Top 0.1%
1.1%
23
Pediatric Research
21 papers in training set
Top 0.3%
1.0%
24
American Journal of Respiratory Cell and Molecular Biology
43 papers in training set
Top 0.6%
0.9%
25
Journal of Cystic Fibrosis
15 papers in training set
Top 0.1%
0.9%
26
Journal of Personalized Medicine
28 papers in training set
Top 1%
0.9%
27
eBioMedicine
183 papers in training set
Top 6%
0.9%
28
Brain, Behavior, and Immunity
116 papers in training set
Top 2%
0.6%
29
Nature Communications
5641 papers in training set
Top 58%
0.6%
30
Cell Communication and Signaling
51 papers in training set
Top 2%
0.6%